
Marc Rose
Get their honest, personalized take on your startup.
Sign in to pitch Marc →At a glance
- Full Name
- Marc S. Rose
- Title
- Founder, Managing Partner, President
- Firm
- Paragon Ventures LLC
- Firm Type
- Healthcare M&A / investment-banking advisory firm
- Target Company Profile
- Established, profitable, private middle-market healthcare and life-sciences companies considering a sale, acquisition, recapitalization, valuation, or strategic exit plan.
- Sector Focus
- Healthcare and life sciences, including pharmacy distribution, home healthcare, respiratory care, infusion therapy, sleep therapy, nursing services, behavioral health, hospice, medical supply, medical device, and related medical technologies.
- Geographic Focus
- United States healthcare M&A; Paragon states it has completed sales in 45 U.S. states.
- Location
- Philadelphia suburban area / Newtown, Pennsylvania
Background
Marc S. Rose is the founder and President of Paragon Ventures, a healthcare-focused M&A advisory firm. Paragon’s site says he has more than 40 years of healthcare experience and began in his family’s pharmacy chain and home health care services business, Medical Home Care Service.
In 1984, Rose led the sale of the family homecare business to Glasrock Home Health Care. After the sale, he held executive positions with Glasrock and worked on growth and acquisition initiatives. In 1991, he left corporate healthcare to form M. S. Rose & Associates, providing executive search and business management services to the home healthcare industry.
Rose founded Paragon Ventures in 1994 to advise healthcare business owners on strategic options, shareholder value, and M&A transactions. Paragon says it has represented owners in the sale of more than 300 businesses and consulted with thousands of owners on M&A, valuations, and long-term exit planning. Rose graduated with honors from Rutgers University in 1979 with degrees in Economics and Psychology.
Investment Thesis & Focus
- Rose is best characterized as a healthcare M&A advisor, not a seed-stage angel investor based on the sources found. I found no verified evidence of personal seed-stage angel investments or check sizes.
- Paragon focuses on “established, profitable, mid-market companies” seeking either acquisition opportunities or exit strategies.
- The firm’s operating thesis is to “Unlock the Value, Create Opportunity and Achieve Results” for healthcare business owners pursuing sales, mergers, divestitures, or recapitalizations.
- Paragon’s process starts with exit-strategy evaluation, business and financial review, market intelligence, and identification of high-value buyers and investors.
- The firm emphasizes strategic and private-equity buyer matching, saying it maintains contact with more than 3,500 prequalified private-equity firms with committed capital and healthcare-related acquisition interests.
- Sector fit matters: Paragon’s forms and sector pages emphasize healthcare provider services, home health/hospice, behavioral health, healthcare IT, pharmacy, medical supply, medical device, infusion, HME/DME, and related ancillary services.
Notable Investments
- Infusion Solutions of Delaware / Access Infusion Care — Paragon announced the April 16, 2026 partnership of Infusion Solutions of Delaware, a physician-led rheumatology and infusion practice, with Access Infusion Care.
- The Charles Pharmacy and Surgical / Strive Medical — Paragon represented The Charles Pharmacy and Surgical in its February 18, 2025 acquisition by Strive Medical, a portfolio company of NMS Capital.
- Homecare California / Family Matters In-Home Care — Paragon served as exclusive advisor to Homecare California in its February 2025 sale to Family Matters In-Home Care.
- Keene Medical Products / AdaptHealth — Paragon acted as exclusive M&A advisor to Keene Medical Products in its April 1, 2022 sale to AdaptHealth.
- Herron & Smith / National Seating and Mobility — Listed by Paragon as a completed transaction in which Paragon acted as exclusive advisor to the seller.
- Psychological Healthcare / Refresh Mental Health — Listed by Paragon as a completed transaction in which Paragon acted as exclusive advisor to the seller.
Unlock the full research
Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.
One-time. Stays unlocked for you.